Alt E, Dechand E, Wirtzfeld A, Ulm K
Dtsch Med Wochenschr. 1983 Mar 4;108(9):331-5. doi: 10.1055/s-2008-1069551.
Survival chances of 2007 patients with pacemaker implantation were determined. For the group as a whole, five-year survival rate was 57%, ten-year survival rate 35%. The prognosis was significantly better in patients with sick-sinus syndrome than those with AV block or brady-arrhythmias. Those with sick-sinus syndrome had an expectancy which was comparable to that of the (age and sex matched) normal population, while those with brady-arrhythmia had a significantly worse ten-year survival rate (24.7%) compared with a normal population (47.8%), P less than 0.01. Since the survival rate in sick-sinus syndrome - with or without pacemaker - is not different to that of the normal population, improved quality of life by preventing symptoms should be balanced against the risk of pacemaker-produced complications when indications for pacemaker treatment are considered.
确定了2007例接受起搏器植入患者的生存几率。对于整个组而言，五年生存率为57%，十年生存率为35%。病态窦房结综合征患者的预后明显好于房室传导阻滞或缓慢性心律失常患者。病态窦房结综合征患者的预期寿命与（年龄和性别匹配的）正常人群相当，而缓慢性心律失常患者的十年生存率（24.7%）与正常人群（47.8%）相比明显更差，P小于0.01。由于病态窦房结综合征患者无论是否植入起搏器，其生存率与正常人群并无差异，因此在考虑起搏器治疗指征时，应权衡通过预防症状改善生活质量与起搏器产生并发症的风险。
